Previous close | 79.35 |
Open | 79.60 |
Bid | 79.82 x 900 |
Ask | 79.85 x 800 |
Day's range | 79.33 - 80.06 |
52-week range | 68.84 - 92.02 |
Volume | |
Avg. volume | 6,822,303 |
Market cap | 106.066B |
Beta (5Y monthly) | 0.75 |
PE ratio (TTM) | 25.90 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.76 (3.48%) |
Ex-dividend date | 19 Dec 2023 |
1y target est | N/A |
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announces that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals. This AI-driven partnership will further capitalize on the achievements already realized with the GI Genius™ intelligent endoscopy module, offering continued innovation and scalable healthcare advancements for patients and caregivers globally. Through this exclusive gl
The board of directors of Medtronic plc (NYSE:MDT) on Thursday, December 7, 2023, approved the company's cash dividend for the third quarter of fiscal year 2024 of $0.69 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2023. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 46 consecutive years. The dividend is payable on January 12, 2024, t
Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2024 (FY24), which ended October 27, 2023.